Schedule 13G ownership disclosure

AVADEL PHARMACEUTICALS PLC

Common Shares · CUSIP: G29687103

Event date: 2025-03-31

Filing-level shares
5,670,682.00
Percent of class
5.9%
  • BRANDES INVESTMENT PARTNERS, LP

    Shares: 5,670,682.00 · Class: 5.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001041062-25-000097
Form type
SCHEDULE 13G
Filer
AVADEL PHARMACEUTICALS PLC
CIK
CIK 1012477
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub